Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3099561 | Journal of Integrative Medicine | 2014 | 9 Pages |
Abstract
Liver fibrosis is a primary cause of liver cirrhosis, and even hepatocarcinoma. Recently, the usage of mesenchymal stem cells (MSCs) has been investigated to improve liver fibrosis. It has been reported that the differentiation, proliferation and migration of MSCs can be regulated by traditional Chinese medicine treatment; however, the mechanisms are still unclear. In this article, the authors review the characteristics of MSCs such as multidirectional differentiation and homing, and its application in animal experiments and clinical trials. The authors also list areas that need further investigation, and look at the future prospects of clinical application of MSCs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Shu Dong, Shi-bing Su,